Free Trial

Coya Therapeutics (COYA) SEC Filings & 10K Form

Coya Therapeutics logo
$5.68 -0.52 (-8.39%)
Closing price 08/14/2025 04:00 PM Eastern
Extended Trading
$5.86 +0.18 (+3.08%)
As of 08:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Coya Therapeutics SEC Filings

DateFilerForm TypeView
08/12/2025
7:34 AM
Coya Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/12/2025
7:06 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2025
7:08 AM
Coya Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/01/2025
7:00 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2025
4:00 PM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2025
4:05 PM
Coya Therapeutics (Filer)
Form DEFA14A
05/16/2025
4:10 PM
Coya Therapeutics (Filer)
Form ARS
05/13/2025
7:07 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2025
7:14 AM
Coya Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/28/2025
4:07 PM
Coya Therapeutics (Filer)
Form 10-K/A
03/18/2025
7:26 AM
Coya Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/18/2025
7:20 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2025
8:30 PM
Coya Therapeutics (Issuer)
ROSS WILBUR L JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
8:30 PM
Coya Therapeutics (Issuer)
Weinand Dieter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
8:30 PM
Coya Therapeutics (Issuer)
GOLDSTEIN DOV A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
8:30 PM
Coya Therapeutics (Issuer)
Villalobos Anabella (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
8:30 PM
Coya Therapeutics (Issuer)
Lee Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
7:35 AM
Coya Therapeutics (Subject)
HIRSCHMAN ORIN (Filed by)
Form SCHEDULE 13G/A
01/13/2025
7:00 AM
Berman Howard (Reporting)
Coya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
7:00 AM
Coya Therapeutics (Issuer)
Grossman Fred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
7:00 AM
Coya Therapeutics (Issuer)
Swaminathan Arun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
7:00 AM
Coya Therapeutics (Issuer)
SNYDER DAVID S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
8:30 PM
Coya Therapeutics (Issuer)
Weinand Dieter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
8:30 PM
Coya Therapeutics (Issuer)
Villalobos Anabella (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
8:30 PM
Coya Therapeutics (Issuer)
Lee Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
8:30 PM
Coya Therapeutics (Issuer)
ROSS WILBUR L JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
8:31 PM
Coya Therapeutics (Issuer)
GOLDSTEIN DOV A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2024
11:15 PM
Coya Therapeutics (Filer)
Form EFFECT
11/29/2024
3:15 PM
Coya Therapeutics (Filer)
Form 424B3
11/20/2024
4:15 PM
Coya Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/14/2024
5:08 PM
Coya Therapeutics (Issuer)
SNYDER DAVID S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
2:37 PM
Coya Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/06/2024
7:06 AM
Coya Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
7:02 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
4:02 PM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
12:27 PM
Coya Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
10:42 AM
Coya Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/31/2024
3:42 PM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
7:00 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
8:08 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2024
8:10 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
He Called Nvidia at $1.10. Now, He Says THIS Stock Will… (Ad)

The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.

See his full breakdown of the seven stocks to own now
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:COYA) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners